Educational charity, Lhasa Limited, has received its second Queen’s Award for Enterprise in a visit from The Vice Lord-Lieutenant of West Yorkshire, Tim Hare.
40 Million EUR European project for new drug safety assessment and integrative data analysis research.
Webinar to showcase data collaboration project
An industry workgroup comprising toxicologists, pharmaceutical companies and data experts plans to unveil the early results of a data sharing project designed to enhance the safety of drug substances and aid compliance with quality guidelines such as ICH M7.
Representatives of Lhasa Limited have attended a reception at Buckingham Palace for the second year in a row.
New data for Vitic Nexus, Vitic Excipients and Vitic Intermediates has been released to members today.
Lhasa Limited, an educational charity which creates state-of-the-art in silico prediction and database systems for use in metabolism, toxicology and related sciences, has been awarded the Queen’s Award for Enterprise for the second year running.
Lhasa Limited, an educational charity which creates state-of-the-art in silico prediction and database systems for use in metabolism, toxicology and related sciences has been recognised for its innovative software.
Drug discovery software specialists combine expertise to extend studies into drug metabolism modelling
CAMBRIDGE and LEEDS, UK 11 April 2017– Optibrium™ and Lhasa Limited (Lhasa), developers of software for small molecule property prediction, design and optimisation, announced today they have formed a collaborative partnership to research next generation drug metabolism modelling. Results from the work will be used by both organisations in the development of future products with improved and extended metabolism prediction capabilities.
eTOXsys is released today, following a 7-year collaboration with key industry players
Lhasa is pleased to announce that it has signed an extension to its Research Collaboration Agreement (RCA) with the US Food and Drug Administration (FDA)